Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity

BACKGROUND: In certain cancers, expression of CXCL16 and its receptor CXCR6 associate with lymphocyte infiltration, possibly aiding anti-tumour immune response. In other cancers, CXCL16 and CXCR6 associate with pro-metastatic activity. In the current study, we aimed to characterise the role of CXCL1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gooden, M J M, Wiersma, V R, Boerma, A, Leffers, N, Boezen, H M, ten Hoor, K A, Hollema, H, Walenkamp, A M E, Daemen, T, Nijman, H W, Bremer, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960624/
https://www.ncbi.nlm.nih.gov/pubmed/24518602
http://dx.doi.org/10.1038/bjc.2014.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960624/
https://www.ncbi.nlm.nih.gov/pubmed/24518602
http://dx.doi.org/10.1038/bjc.2014.55

Ejemplares similares